<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02628093</url>
  </required_header>
  <id_info>
    <org_study_id>1403014955</org_study_id>
    <nct_id>NCT02628093</nct_id>
  </id_info>
  <brief_title>A ProspectiveTrial Comparing THUNDERBEAT to the Ligasure Energy Device During Laparoscopic Colon Surgery</brief_title>
  <official_title>A Randomized Controlled Trial Comparing THUNDERBEAT to the Ligasure Energy Device During Laparoscopic Colon Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Weill Medical College of Cornell University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Olympus</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Weill Medical College of Cornell University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective randomized controlled study, at Colon and Rectal Surgery, WMC/NYPH. Subjects
      undergoing Laparoscopic Left Colectomy will be randomized into 1 of 2 groups based on the
      instrument used for tissue dissection and vessel ligation: Group 1 - THUNDERBEAT Group 2

      - Ligasure Population
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective randomized controlled study, at Colon and Rectal Surgery, WMC/NYPH. Subjects
      undergoing Laparoscopic Left Colectomy will be randomized into 1 of 2 groups based on the
      instrument used for tissue dissection and vessel ligation: Group 1 - THUNDERBEAT Group 2

      - Ligasure Population: 60 subjects, with colon neoplasm or diverticulitis will be invited in
      the study after surgery is deemed necessary Study Procedures: This project will consist only
      of prospective data collection. No interventions will be done for research purpose. Data will
      be collected prospectively on: -Patients (before, during and after surgery) -The THUNDERBEAT
      and LigaSure instruments Data will be collected on data collection sheets and entered in a
      password protected database Primary Outcomes/Definitions- Overall time for dissection of the
      soft tissues necessary for specimen removal during colon resection, measured in minutes, from
      the start of colon mobilization to specimen removal from the abdominal cavity.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 17, 2016</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall time for dissection of the soft tissues</measure>
    <time_frame>up to 5 weeks</time_frame>
    <description>from the start of colon mobilization to specimen removal from the abdominal cavity</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>dissection time for each stage of the surgery</measure>
    <time_frame>up to 5 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Colon Cancer</condition>
  <arm_group>
    <arm_group_label>THUNDERBEAT</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>THUNDERBEAT energy device ( Olympus) will be used for dissection of tissue and ligation of vessels</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LIGASURE</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>LIGASURE energy device will be used for dissection of tissue and ligation of vessels</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>THUNDERBEAT</intervention_name>
    <description>Tissue dissection and vessels ligation</description>
    <arm_group_label>THUNDERBEAT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LIGASURE</intervention_name>
    <description>Tissue dissection and vessels ligation</description>
    <arm_group_label>LIGASURE</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients that will be undergoing a Left Laparoscopic Colon Resection

          -  Older than 18 years old

          -  ASA 1 to 3

          -  Elective surgeries

          -  Patients who willingly provide informed consent

        Exclusion Criteria:

          -  Morbidly obese patients (BMI &gt;35)

          -  Patients with acute diverticulitis

          -  Patients with multiple previous abdominal surgeries

          -  Patients on anticoagulants

          -  Patients who can not, tolerate a major surgery

          -  Patients for whom electrosurgery is contraindicated

          -  Patients who are pregnant

          -  Patient with IBDs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeffrey Milsom, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>WCMC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Koiana Trencheva, M.S.</last_name>
    <phone>646-962-2342</phone>
    <email>kivanova@med.cornell.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Weill Cornell Medical Center- NYPH</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Koiana Trencheva, RN,BSN,M.S</last_name>
      <email>kivanova@med.cornell.edu</email>
    </contact>
    <investigator>
      <last_name>Jeffrey W Milsom, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 4, 2015</study_first_submitted>
  <study_first_submitted_qc>December 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 11, 2015</study_first_posted>
  <last_update_submitted>July 10, 2017</last_update_submitted>
  <last_update_submitted_qc>July 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Weill Medical College of Cornell University</investigator_affiliation>
    <investigator_full_name>Jeffrey W. Milsom</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glucuronyl glucosamine glycan sulfate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

